In the last years, DS/DR methods allowed both an in depth understanding of SMA pathological mechanisms and the identification of therapeutic approaches, including enhancing SMN function and regulating the SMN exon seven splicing. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.